Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Haematologica·2026
Same author

Equity in Population-Wide Genomic Screening.

JAMA network open·2026
Same author

A scalable deep-learning framework for cancer detection using cell-free DNA shallow whole-genome sequencing.

Science advances·2026
Same author

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026
Same author

Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe.

European radiology·2026
Same author

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026

Related Experiment Video

Updated: Mar 25, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K

Implementation of the NHS England Lung Cancer Screening Programme over 5 years.

Richard W Lee1,2,3,4, Arjun Nair5, Haval Balata6,7

  • 1The Early Diagnosis and Detection Centre, The Royal Marsden NHS Foundation Trust, London, UK. Richard.Lee@rmh.nhs.uk.

Nature Medicine
|March 24, 2026
PubMed
Summary

The UK's national lung cancer screening program has successfully invited over two million people, diagnosing thousands of early-stage lung cancers. This initiative demonstrates effective large-scale implementation and supports global adoption of lung cancer screening.

More Related Videos

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

7.1K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K

Related Experiment Videos

Last Updated: Mar 25, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.2K
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
05:49

Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking

Published on: October 10, 2019

7.1K
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K

Area of Science:

  • Public Health
  • Oncology
  • Radiology

Background:

  • Low-dose computed tomography (LDCT) screening reduces lung cancer mortality.
  • The NHS England Targeted Lung Health Check Programme, launched in 2019, is expanding nationally.
  • Lung cancer screening aims to improve survival rates through early detection.

Purpose of the Study:

  • To report the progress and outcomes of the NHS England Lung Cancer Screening Programme.
  • To assess the effectiveness of large-scale implementation of lung cancer screening.
  • To evaluate the program's impact on early-stage lung cancer diagnosis.

Main Methods:

  • Targeted individuals aged 55-74 who have ever smoked and met risk thresholds.
  • Utilized low-dose computed tomography (LDCT) of the thorax for screening.
  • Employed regionally federated clinical infrastructure with national strategic frameworks.

Main Results:

  • Over two million individuals invited; 7,193 lung cancers diagnosed by March 2025.
  • 63.1% of diagnosed cancers were Stage 1, and 12.6% were Stage 2.
  • Increased early-stage lung cancer detection, especially in deprived areas.

Conclusions:

  • The NHS England program demonstrates feasibility, scalability, and effective implementation.
  • Early-stage diagnosis has improved, particularly in socioeconomically deprived regions.
  • Supports wider adoption of lung cancer screening in the UK and globally, with a need to address participation inequalities.